Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer is one of 9,000 studies in the ScholarPulse dataset. Key details — Authors: Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp; Journal / source: New England Journal of Medicine; Year: 2016.
| Authors | Martin Reck, Delvys Rodríguez‐Abreu, Andrew Robinson, Rina Hui, Tibor Csőszi, Andrea Fülöp |
|---|---|
| Journal / source | New England Journal of Medicine |
| Year | 2016 |
| Field | Cancer Immunotherapy and Biomarkers |
| Times cited | 10074 |
| Type | article |
| DOI / link | https://doi.org/10.1056/nejmoa1606774 |